Adding a Lower Cutoff Value for CA19-9 May Identify Additional High-risk Cases of Pancreatic Cancer
CA19-9 is a biomarker whose levels often correlate with pancreatic cancer stage and prognosis PHILADELPHIA – A dual-threshold model...
Search/Filter
Loading...
Targeted, High-dose Radiation May Improve Treatment for ‘Supermassive’ Bile Duct Tumors
Patients with very large intrahepatic cholangiocarcinoma experienced improved outcomes when targeted, high-dose radiation was added to chemotherapy PHILADELPHIA –...
A Machine Learning Model May Enable Liver Cancer Risk Prediction With Routine Clinical Information
PHILADELPHIA – A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test results...
High Consumption of Ultraprocessed Foods May Be Linked to Cancer Survivors’ Risk of Death
PHILADELPHIA – Cancer survivors who consumed higher amounts of ultraprocessed foods as part of their diet had a significantly...
Investigational Blood Biomarker Panel May Improve Detection of Pancreatic Cancer
PHILADELPHIA – A four-biomarker blood panel of aminopeptidase N (ANPEP), polymeric immunoglobulin receptor (PIGR), CA19-9, and thrombospondin-2 (THBS2) enhanced...
Elizabeth M. Jaffee, MD, FAACR, and Antoni Ribas, MD, PhD, FAACR, Named New Editors-in-Chief of the AACR Journal Cancer Immunology Research
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced the appointment of Elizabeth M. Jaffee, MD, FAACR, and Antoni Ribas,...
ctDNA Levels After Neoadjuvant Therapy May Predict Breast Cancer Recurrence Better Than Pathologic Complete Response
ctDNA status after neoadjuvant therapy may also inform adjuvant therapy PHILADELPHIA – The presence of circulating tumor DNA (ctDNA)...
Ross Levine, MD, Selected as Editor-in-Chief of the AACR Journal Blood Cancer Discovery
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced the appointment of Ross Levine, MD, as editor-in-chief...
AACR Expresses Support for FDA’s Proposed Rule to Decrease Nicotine Content in Certain Combusted Tobacco Products
PHILADELPHIA – The American Association for Cancer Research (AACR) today released a policy statement in support of a rule proposed...
A Combination Treatment May Help Cut Lifelong Ibrutinib for Chronic Lymphocytic Leukemia
PHILADELPHIA – Adding the investigational antibody ianalumab (VAY736) to ibrutinib (Imbruvica) allowed some patients with chronic lymphocytic leukemia (CLL)...